Disease on EC 7.6.2.15 - ABC-type thiamine transporter
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Adenocarcinoma
Interaction of 2,4-Diaminopyrimidine-Containing Drugs Including Fedratinib and Trimethoprim with Thiamine Transporters.
Anemia
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.
Anemia
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Anemia
Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: First case report from Kashmir Valley of the Indian subcontinent.
Anemia
Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.
Anemia
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Anemia, Megaloblastic
A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I.
Anemia, Megaloblastic
Cloning of the human thiamine transporter, a member of the folate transporter family.
Anemia, Megaloblastic
Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.
Anemia, Megaloblastic
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.
Anemia, Megaloblastic
First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Anemia, Megaloblastic
Leber's Congenital Amaurosis as the Retinal Degenerative Phenotype in Thiamine Responsive Megaloblastic Anemia: A Case Report.
Anemia, Megaloblastic
Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
Anemia, Megaloblastic
Mitochondria from cultured cells derived from normal and thiamine-responsive megaloblastic anemia individuals efficiently import thiamine diphosphate.
Anemia, Megaloblastic
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
Anemia, Megaloblastic
Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
Anemia, Megaloblastic
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Anemia, Megaloblastic
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
Anemia, Megaloblastic
Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: First case report from Kashmir Valley of the Indian subcontinent.
Anemia, Megaloblastic
Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.
Anemia, Megaloblastic
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Anemia, Megaloblastic
Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Basal Ganglia Diseases
Neuropathological characteristics of the brain in two patients with SLC19A3 mutations related to the biotin-thiamine-responsive basal ganglia disease.
Basal Ganglia Diseases
Stress-Induced Upregulation of SLC19A3 is Impaired in Biotin-Thiamine-Responsive Basal Ganglia Disease.
Brain Diseases
Biotin-responsive basal ganglia disease: a case diagnosed by whole exome sequencing.
Brain Diseases
Genome-Wide Association Analysis Identifies a Mutation in the Thiamine Transporter 2 (SLC19A3) Gene Associated with Alaskan Husky Encephalopathy.
Brain Diseases
Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.
Breast Neoplasms
Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.
Breast Neoplasms
Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line.
Breast Neoplasms
Low-thiamine diet increases mammary tumor latency in FVB/N-Tg(MMTVneu) mice.
Breast Neoplasms
Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters.
Breast Neoplasms
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
Deafness
A novel mutation in the thiamine responsive megaloblastic anaemia gene SLC19A2 in a patient with deficiency of respiratory chain complex I.
Deafness
Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
Deafness
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
Deafness
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
Deafness
Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: First case report from Kashmir Valley of the Indian subcontinent.
Deafness
Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.
Deafness
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Diabetes Mellitus
Analysis of slc19a2, on 1q23.3 encoding a thiamine transporter as a candidate gene for type 2 diabetes mellitus in pima indians.
Diabetes Mellitus
First 2 cases with thiamine-responsive megaloblastic anemia in the Czech Republic, a rare form of monogenic diabetes mellitus: a novel mutation in the thiamine transporter SLC19A2 gene-intron 1 mutation c.204+2T>G.
Diabetes Mellitus
Thiamine Prevents Obesity and Obesity-Associated Metabolic Disorders in OLETF Rats.
Diabetes Mellitus
Thiamine responsive megaloblastic anemia syndrome associated with patent ductus arteriosus: First case report from Kashmir Valley of the Indian subcontinent.
Diabetes Mellitus
Thiamine transporter mutation: an example of monogenic diabetes mellitus.
Diabetes Mellitus
Thiamine withdrawal can lead to diabetic ketoacidosis in thiamine responsive megaloblastic anemia: report of two siblings.
Diabetes Mellitus
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
Diabetes Mellitus
Thiamine-responsive megaloblastic anemia: early diagnosis may be effective in preventing deafness.
Diabetes Mellitus, Type 1
Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.
Diabetes Mellitus, Type 2
Analysis of slc19a2, on 1q23.3 encoding a thiamine transporter as a candidate gene for type 2 diabetes mellitus in pima indians.
Diabetes Mellitus, Type 2
Thiamine Prevents Obesity and Obesity-Associated Metabolic Disorders in OLETF Rats.
Diabetic Retinopathy
Thiamine transporter 2 is involved in high glucose-induced damage and altered thiamine availability in cell models of diabetic retinopathy.
Dystonia
Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency.
Genetic Diseases, Inborn
The Effects of Genetic Mutations and Drugs on the Activity of the Thiamine Transporter, SLC19A2.
Hearing Loss, Sensorineural
Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.
Hearing Loss, Sensorineural
Thiamine-responsive megaloblastic anemia syndrome: a novel mutation.
Hyperglycemia
Reduced Thiamine Availability and Hyperglycemia Impair Thiamine Transport in Renal Glomerular Cells through Modulation of Thiamine Transporter 2.
Hypertension
Association of a SNP in SLC35F3 Gene with the Risk of Hypertension in a Chinese Han Population.
Infections
Reduced Folate Carrier: an Entry Receptor for a Novel Feline Leukemia Virus Variant.
Infertility, Male
Male infertility and thiamine-dependent erythroid hypoplasia in mice lacking thiamine transporter Slc19a2.
Korsakoff Syndrome
Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS).
Leigh Disease
Thiamine metabolism is critical for regulating correlated growth of dendrite arbors and neuronal somata.
Leukemia
Dietary thiamine influences l-asparaginase sensitivity in a subset of leukemia cells.
Microcephaly
Thiamine metabolism is critical for regulating correlated growth of dendrite arbors and neuronal somata.
Neoplasms
Down-regulation of thiamine transporter THTR2 gene expression in breast cancer and its association with resistance to apoptosis.
Neoplasms
Functional and mechanistic roles of the human proton-coupled folate transporter transmembrane domain 6-7 linker.
Neoplasms
Thiamine transporter gene expression and exogenous thiamine modulate the expression of genes involved in drug and prostaglandin metabolism in breast cancer cells.
Nervous System Diseases
Thiamine metabolism is critical for regulating correlated growth of dendrite arbors and neuronal somata.
Neurodegenerative Diseases
High-dose thiamine prevents brain lesions and prolongs survival of Slc19a3-deficient mice.
Thiamine Deficiency
Drug-nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3).
Wernicke Encephalopathy
Stress-Induced Upregulation of SLC19A3 is Impaired in Biotin-Thiamine-Responsive Basal Ganglia Disease.
html completed